Company Overview
RIGEL PHARMACEUTICALS INC
RIGLRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
310M
2025 FY
Net Income
367M
2025 FY
Shares Outstanding
18M
2025 FY
EPS
20.4USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1034842
Exchange
Nasdaq
Location
US